SRPT
Sarepta Therapeutics Inc
Price:  
114.08 
USD
Volume:  
544,454.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRPT WACC - Weighted Average Cost of Capital

The WACC of Sarepta Therapeutics Inc (SRPT) is 8.0%.

The Cost of Equity of Sarepta Therapeutics Inc (SRPT) is 8.40%.
The Cost of Debt of Sarepta Therapeutics Inc (SRPT) is 4.40%.

Range Selected
Cost of equity 7.10% - 9.70% 8.40%
Tax rate 0.20% - 0.90% 0.55%
Cost of debt 4.00% - 4.80% 4.40%
WACC 6.8% - 9.2% 8.0%
WACC

SRPT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.7 0.86
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 9.70%
Tax rate 0.20% 0.90%
Debt/Equity ratio 0.11 0.11
Cost of debt 4.00% 4.80%
After-tax WACC 6.8% 9.2%
Selected WACC 8.0%